logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 울산지방법원 2020.09.23 2020고단3293
약사법위반
Text

Defendant

A The defendant shall be punished by imprisonment with prison labor for a year and six months and by a fine of twenty million won.

The above fine shall not be paid by the defendant.

Reasons

Punishment of the crime

Defendant

A on December 1, 2005, the Seoul Central District Court has been sentenced to a suspended sentence of three years and a fine of ten million won for a year of imprisonment for a violation of the Pharmaceutical Affairs Act at the Seoul Central District Court.

1. Defendant A

(a) A person who intends to engage in the business of manufacturing medicines for assessment delay shall have necessary facilities in accordance with the facility standards prescribed by Presidential Decree and obtain permission from the Minister of Food and Drug Safety, as prescribed by Ordinance of the Prime Minister;

The Defendant, without obtaining permission from the Minister of Food and Drug Safety from around September 2019, equipped with manufacturing facilities for pharmaceutical products, such as mixing machines, packaging pressure machines, and compact showers, on the G and 1st floor in Gyeonggi-do Kimpo-si, Kimpo-si, Gyeonggi-do. From that time until July 13, 2020, up to July 13, 202, the Defendant deemed 7,800 of “procococococis” (15,962; 12 p. 38,529, “procococis” (160,000, 60, 630, 40, 50, 40, 808, 800, 800, 400, 80, 400, 80, 80, 80, 40, etc.).

(b) No person, other than a pharmacy founder, may sell or obtain drugs for the purpose of selling them;

On October 1, 2019, the Defendant sold the fact delay system, which is a medicine, to adult product wholesalers, 97 times in total from July 8, 2020, as shown in the list of crimes in the attached Table, to the 5 box for delay in the situation manufactured as described in the above paragraph (a) in E located in Incheon Strengthening-gun, Incheon, as well as to the sales of the 5 box for adult product wholesalers.

(c) Any person who intends to engage in the business of manufacturing medicines for pre-donation drugs shall have necessary facilities and obtain permission from the Minister of Food and Drug Safety, as prescribed by Ordinance of the Prime Minister.

The defendant.

arrow